Vecuronium

Question 1

Trade name

Answer 1

Norcuron

Question 2

Class

Answer 2

Long-acting, non-depolarizing paralytic agent

Question 3

Mechanism of action

Answer 3

Non depolarizing neuromuscular blocking agent, Skeletal muscle relaxant including ,respiratory muscles

Question 4

Indications

Answer 4

To facilitate intubation, to terminate laryngospasm, pro promote muscular relaxation

Question 5

Contraindications

Answer 5

Inability to control airway or support ventilations with oxygen and positive pressure

Question 6

Adverse effects

Answer 6

Apnea, dysrhythmias, transient hypotension or hypertension, tachycardia.

Question 7

Incompatibilities/ drug interactions

Answer 7

Non in pre hospital setting

Question 8

Routs of admin

Answer 8

IV/IO

Question 9

Onset of action

Answer 9

Onset within 2-3 min. duration of 30-45min

Question 10

Adult dose

Answer 10

0.1mg/kg IV/IO; repeat as needed

Question 11

Pediatric dose

Answer 11

0.1mg/kg IV/IO repeat as needed

Question 12

Special notes

Answer 12

Always sedate prior to the administration of vecuromium
Intubation and ventilatory support must be readily available, Vecuronium has no effect on consciousness or pain. Administer pain analgesics as indicated
Will not stop neuronal seizure activity. Andimister anti-convulsant as indicated
Pregnancy safety: category C

Question 13

Protocols used

Answer 13

E-17: RSI